動物用疼痛管理市場- 世界の産業規模、シェア、動向、機会、予測、製品タイプ別、用途別、動物タイプ別、地域別、競合別、2020-2030年

動物用疼痛管理の世界市場は、2024年には29億4,000万米ドルと評価され、2030年には43億4,000万米ドルに達すると予測され、予測期間中のCAGRは6.71%で成長すると予測されています。

同市場は、遺伝性疾患や欠乏症など、動物における疼痛性・炎症性疾患の罹患率の上昇に牽引され、顕著な拡大を見せています。このような有病率の増加は、動物の健康と福祉に対する意識の高まりと相まって、効率的で利用しやすい疼痛管理ソリューションに対する需要を促進しています。特に都市部では、手頃な治療と獣医学的インフラの充実が重視され、導入が増加しています。コンパニオンアニマルの飼育率が上昇し続け、治療への期待が高まるにつれ、包括的で予防的な獣医学的ケアへの幅広いシフトも市場の利益となっています。

市場促進要因

ペット飼育の増加とコンパニオンアニマル支出の増加

主な市場課題

地方および低所得地域における動物用疼痛管理へのアクセス制限

主要市場動向

ドラッグデリバリーシステムと非侵襲的治療の進歩

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の動物用疼痛管理市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別（医薬品、医療機器）
  • 用途別（関節痛、がん性疼痛、術後疼痛、その他）
  • 動物の種類別（コンパニオンアニマル、家畜）
  • 地域別
  • 企業別（2024）
• 市場マップ
  • 製品別
  • 用途別
  • 動物の種類別
  • 地域別

第6章 北米の動物用疼痛管理市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州の動物用疼痛管理市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の動物用疼痛管理市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米の動物用疼痛管理市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの動物用疼痛管理市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 世界の動物用疼痛管理市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威/サービス

第15章 競合情勢

• Boehringer Ingelheim International GmbH
• Zoetis Inc.

第15章 3エランコ・アニマルヘルス社

• ノーブルック・ラボラトリーズ・リミテッド
• シークエント・サイエンティフィック・リミテッド
• メルク社
• デクラ・ファーマシューティカルズ社
• ベトキノールS.A.
• チェヴァ・サンテ・アニマーレSA
• シャネルファーマグループ株式会社

第16章 戦略的提言

第17章 調査会社について・免責事項

The Global Veterinary Pain Management Market was valued at USD 2.94 billion in 2024 and is projected to reach USD 4.34 billion by 2030, growing at a CAGR of 6.71% during the forecast period. The market is witnessing notable expansion driven by a rising incidence of painful and inflammatory conditions in animals, such as hereditary disorders and deficiency diseases. This growing prevalence, coupled with heightened awareness around animal health and welfare, is fostering demand for efficient and accessible pain management solutions. Urban regions, in particular, are seeing increased adoption due to the emphasis on affordable treatments and better veterinary infrastructure. As companion animal ownership continues to rise and treatment expectations evolve, the market is also benefiting from a broader shift toward comprehensive and preventive veterinary care.

Key Market Drivers

Increasing Pet Ownership and Companion Animal Expenditures

The surge in pet ownership globally, especially in both developed and emerging economies, is significantly propelling the veterinary pain management market. Pets, particularly cats and dogs, are increasingly seen as integral family members, resulting in higher spending on their healthcare needs. This trend is encouraging pet owners to seek advanced treatments for both acute and chronic pain conditions, thereby increasing the demand for veterinary pain management solutions.

Key Market Challenges

Limited Access to Veterinary Pain Management in Rural and Low-Income Regions

One of the foremost challenges in the global veterinary pain management market is the limited availability of services and medications in rural and low-income areas. These regions often lack essential veterinary infrastructure, skilled professionals, and necessary medications. In low- and middle-income countries (LMICs), veterinary care is largely reactive and lacks emphasis on pain relief. The World Organisation for Animal Health (WOAH) indicates that over 45% of surveyed countries report insufficient veterinary service coverage in rural zones, primarily due to limited funding. Additionally, cultural perceptions and a lack of education on animal pain further contribute to the under-treatment of painful conditions. Advanced pain-relief therapies like laser treatment or multimodal analgesic regimens are rarely economically feasible for livestock owners in these areas. Furthermore, national health budgets in LMICs typically allocate minimal resources to veterinary care, with little focus on pain management, hindering market growth.

Key Market Trends

Advancements in Drug Delivery Systems and Non-Invasive Therapies

Technological innovations in drug delivery and therapy methods are transforming the landscape of veterinary pain management. The market is witnessing a shift from traditional oral and injectable drugs toward more animal-friendly formats like chewable tablets, transdermal patches, and long-acting injectables. These innovations offer improved efficacy, easier administration, and greater compliance. Sustained-release formulations, for instance, provide long-term relief with fewer doses, proving especially effective for chronic conditions such as osteoarthritis. Non-invasive therapies like cold laser therapy, pulsed electromagnetic field (PEMF) therapy, and acupuncture are gaining popularity as they minimize reliance on pharmaceutical interventions. Such approaches are appealing to pet owners looking to avoid long-term drug use due to concerns about side effects. Support from government-funded research initiatives in countries like the U.S., Canada, and the UK is accelerating these advancements, making pain management both more effective and accessible.

Key Market Players

• Boehringer Ingelheim International GmbH
• Zoetis Inc.
• Elanco Animal Health Incorporated
• Norbrook Laboratories Limited
• SeQuent Scientific Limited
• Merck & Co., Inc.
• Dechra Pharmaceuticals Plc
• Vetoquinol S.A.
• Ceva Sante Animale SA
• Chanelle Pharma Group Ltd

Report Scope:

In this report, the Global Veterinary Pain Management Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Pain Management Market, By Product:

• Medications
• Medical Devices

Veterinary Pain Management Market, By Application:

• Joint Pain
• Cancer Pain
• Postoperative Pain
• Others

Veterinary Pain Management Market, By Animal Type:

• Companion Animal
• Livestock Animal

Veterinary Pain Management Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Pain Management Market.

Available Customizations:

Global Veterinary Pain Management Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Pain Management Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Medications, Medical Devices)
  • 5.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
  • 5.2.3. By Animal Type (Companion Animal, Livestock Animal)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map
  • 5.3.1. By Product
  • 5.3.2. By Application
  • 5.3.3. By Animal Type
  • 5.3.4. By Region

6. North America Veterinary Pain Management Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product (Medications v/s Medical Devices)
  • 6.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
  • 6.2.3. By Animal Type (Companion Animal v/s Livestock Animal)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Veterinary Pain Management Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Animal Type
  • 6.3.2. Mexico Veterinary Pain Management Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Animal Type
  • 6.3.3. Canada Veterinary Pain Management Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Animal Type

7. Europe Veterinary Pain Management Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product (Medications v/s Medical Devices)
  • 7.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
  • 7.2.3. By Animal Type (Companion Animal v/s Livestock Animal)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Veterinary Pain Management Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Animal Type
  • 7.3.2. Germany Veterinary Pain Management Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Animal Type
  • 7.3.3. United Kingdom Veterinary Pain Management Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Animal Type
  • 7.3.4. Italy Veterinary Pain Management Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Animal Type
  • 7.3.5. Spain Veterinary Pain Management Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Animal Type

8. Asia-Pacific Veterinary Pain Management Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product (Medications v/s Medical Devices)
  • 8.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
  • 8.2.3. By Animal Type (Companion Animal v/s Livestock Animal)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Veterinary Pain Management Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Animal Type
  • 8.3.2. India Veterinary Pain Management Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Animal Type
  • 8.3.3. South Korea Veterinary Pain Management Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Animal Type
  • 8.3.4. Japan Veterinary Pain Management Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Animal Type
  • 8.3.5. Australia Veterinary Pain Management Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Animal Type

9. South America Veterinary Pain Management Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product (Medications v/s Medical Devices)
  • 9.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
  • 9.2.3. By Animal Type (Companion Animal v/s Livestock Animal)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Veterinary Pain Management Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Animal Type
  • 9.3.2. Argentina Veterinary Pain Management Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Animal Type
  • 9.3.3. Colombia Veterinary Pain Management Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Animal Type

10. Middle East and Africa Veterinary Pain Management Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product (Medications v/s Medical Devices)
  • 10.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
  • 10.2.3. By Animal Type (Companion Animal v/s Livestock Animal)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Veterinary Pain Management Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Animal Type
  • 10.3.2. Saudi Arabia Veterinary Pain Management Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Animal Type
  • 10.3.3. UAE Veterinary Pain Management Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Animal Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Veterinary Pain Management Market: SWOT Analysis

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products/Services

15. Competitive Landscape

• 15.1. Boehringer Ingelheim International GmbH
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Zoetis Inc.

15.3 Elanco Animal Health Incorporated

• 15.4. Norbrook Laboratories Limited
• 15.5. SeQuent Scientific Limited
• 15.6. Merck & Co., Inc.
• 15.7. Dechra Pharmaceuticals Plc
• 15.8. Vetoquinol S.A.
• 15.9. Ceva Sante Animale SA
• 15.10. Chanelle Pharma Group Ltd

16. Strategic Recommendations

17. About Us & Disclaimer